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UL44∆NLS, either expressed alone or in the presence of wild-type or mutant DsRed2-UL44 2 fusions, in COS-7 cells transfected with these plasmids was analyzed by confocal laser scanning 3 microscopy (CLSM) as described (3). We have previously shown that this assay can efficiently 4 detect dimerization of UL44 in living cells, and that a large deletion of UL44, as expected, impairs 5 its dimerization (3). When expressed alone, GFP-UL44∆NLS localized exclusively in the 6 cytoplasm, while its coexpression with DsRed2-UL44 resulted in marked relocalization of UL44∆NLS to the nucleus (Fig. 1A) . DsRed2-UL44-P85G, a mutant which dimerizes in vitro (6), 8 and DsRed2-UL44-I135A, a mutant bearing a substitution that in vitro prevents binding of UL44 to 9 UL54 (16) but not UL44 dimerization (unpublished results), also colocalized with GFP-UL44∆NLS 10 into the nucleus (Fig. 1A) . In contrast, coexpression with DsRed2-UL44-F121A or DsRed2-UL44-11 L86A/L87A did not result in marked relocalization of GFP-UL44∆NLS into the nucleus (Fig. 1A) , 12 suggesting that these mutants cannot efficiently dimerize with GFP-UL44∆NLS. 13 To quantify the effects of the F121A and L86A/L87A substitutions on UL44 dimerization, we 14 first determined the levels of nuclear accumulation of GFP-UL44∆NLS when expressed alone or in 15 the presence of wild-type or mutant DsRed2-UL44 fusions in experiments such as those in Fig. 1A . 16 Measurement of the nuclear/cytoplasmic fluorescence ratio (Fn/c) values as described (3, 4) 17 revealed that coexpression with DsRed2-UL44, DsRed2-UL44-P85G, or DsRed2-UL44-I135A 18 significantly enhanced the nuclear accumulation of GFP-UL44∆NLS ( Fig. 1C and Table 1 ). In 19 contrast, coexpression with DsRed2-UL44-F121A or DsRed2-UL44-L86A/L87A resulted in 20 significantly lower nuclear accumulation of GFP-UL44∆NLS, with the L86A/L87A substitutions 21 having the stronger effect ( Fig. 1C and Table 1 ).
22
We then wished to examine the effects of the F121A and L86A/L87A substitutions when 23 present in both UL44 monomers, as this would better mimic the situation during the infection with 24 virus containing these mutations. Thus, we introduced the F121A or L86A/L87A substitutions in the GFP-UL44∆NLS fusion and determined the levels of nuclear accumulation of the mutants when 1 expressed alone or in the presence of DsRed2-UL44 fusions bearing the same mutations. As 2 expected, when expressed alone GFP-UL44∆NLS, GFP-UL44∆NLS-F121A, and GFP-3 UL44∆NLS-L86A/L87A localized mainly in the cytoplasm (Fig. 1A and data not shown) . 4 Quantitative analysis revealed that both mutant proteins partially entered the nucleus, and did so 5 more efficiently than GFP-UL44∆NLS (Fn/c of 0.42 and 0.59, respectively, vs. 0.20; Table 1),   6 perhaps due to monomers of the UL44 dimerization-defective mutants passively diffusing through 7 nuclear pores due to their smaller molecular mass (3). Importantly, measurement of the Fn/c values 8 upon coexpression of GFP-UL44∆NLS-F121A with DsRed2-UL44-F121A, and of GFP-9 UL44∆NLS-L86A/L87A with DsRed2-UL44-L86A/L87A showed that when the substitutions are 10 present in both monomers the F121A mutant can dimerize to a larger extent than the L86A/L87A 11 mutant (Table 1) , consistent with previous biochemical data (6). Nevertheless, the Fn/c values were 12 significantly reduced compared to those of wild-type constructs ( To examine the possibility that the observed effects of the L86A/L87A and F121A 17 substitutions could be due to misfolding, we tested the ability of the DsRed2-UL44 fusions to 18 interact with GFP-UL54(1213-1242), a construct containing the UL54 binding domain for UL44 (4, 19 15). When expressed individually, GFP-UL54(1213-1242) localized both in the nucleus and in the 20 cytoplasm (Fig. 1B) , due to its small molecular mass and lack of a functional NLS (4).
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Coexpression with the wild-type DsRed2-UL44 fusion as well as with the DsRed2-UL44-22 L86A/L87A, DsRed2-UL44-F121A, and DsRed2-UL44-P85G mutants resulted in extensive 23 colocalization of GFP-UL54(1213 -1242 To further examine the behavior of the UL44-F121A and UL44-L86A/L87A mutants in a 6 cellular context, we analyzed the subcellular localization of the GFP-UL44-F121A and GFP-UL44-7 L86A/L87A fusions, which bear functional NLS's (2), when transiently expressed in COS-7 cells as 8 compared to GFP-UL44 and to GFP-UL44-P85G and GFP-UL44-I135A mutants as controls. As 9 expected, all UL44 mutants localized into the nucleus like the wild-type protein ( Fig. 2A ). sites of pSI (Promega). The pSI-UL44-P85G, pSI-UL44-L86A/L87A, pSI-UL44-F121A, and pSI-7 UL44-I135A plasmids were generated by amplifying pSI-UL44 with mutagenic primers (see Table   8 1 footnotes). Replication of pSP50 was detected by treatment of transfected cell DNA with DpnI, analysis showed that all mutants are expressed at levels similar to that of wild-type UL44, 17 suggesting that the inability of UL44-L86A/L87A, F121A, and I135A mutants to support DNA 18 replication is not due to reduced protein expression (Fig. 3B) . 19 Thus, our study strongly suggests that UL44 dimerization is a prerequisite for supporting 20 DNA replication in cells, as mutations that specifically affect dimerization of UL44 also impair its 21 ability to complement oriLyt-mediated DNA synthesis. Noteworthy, although the F121A mutation 22 still permits a certain degree of dimerization, this appears to be not sufficient to support DNA 23 replication. Since it has previously shown that UL44 mutants that are impaired in dimerization are 24 also impaired in binding DNA in vitro (6), our results suggest that in order for UL44 to fulfill its 25 processivity function, it must homodimerize to bind DNA and thereby tether UL54 on the template. Given its structural similarity to PCNA, the dimeric nature of UL44 could allow for the second 7 subunit to act as a scaffold to recruit other viral or cellular proteins during viral DNA replication. Whatever the mechanism may be, our results strongly argue that compounds that interfere 14 with UL44 dimerization could block viral DNA synthesis and thereby effectively prevent HCMV 15 replication. Thus, it is our hope that this will lead to the discovery of clinically useful anti-HCMV 16 drugs and will also suggest similar strategies for inhibiting other herpesvirus polymerases or, more 17 generally, other targets (17, 18). 
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